Paragon Bioservices Competitors, Revenue, Alternatives and Pricing

Claim your profile


Baltimore, MD USA
Total Funding:$20M
Lead Investor(s):NewSpring Capital, Camden Partners

Estimated Revenue & Financials

  • Paragon Bioservices's estimated annual revenue is currently $60.6M per year.(?)
  • Paragon Bioservices received $5.0M in venture funding in August 2018.
  • Paragon Bioservices's estimated revenue per employee is $155,000
  • Paragon Bioservices's total funding is $20M.

Employee Data

  • Paragon Bioservices has 391 Employees.(?)
  • Paragon Bioservices grew their employee count by -5% last year.
  • Paragon Bioservices currently has 89 job openings.

Paragon Bioservices is an industry-leading, private-equity backed contract development and manufacturing organization (CDMO) whose focus is the development and manufacturing of cutting-edge biopharmaceuticals. Paragon's aim is to build strong client partnerships with the world's best biotech and pharma companies, focusing on transformative technologies, including gene therapies (AAV), next-generation vaccines, oncology immunotherapies (oncolytic viruses and CAR-T cell therapies), therapeutic protein, and other complex biologics.